Search the Newsreel

Truist Securities Downgrades Insulet Corporation (PODD) to Hold

Truist Securities analyst Richard Newitter has downgraded Insulet Corporation (NASDAQ: PODD) from Buy to Hold, setting a new price target of $153.00. The article notes that further details are available to premium subscribers of StreetInsider.com.

Why Insulet (PODD) Shares Are Sliding Today

Insulet Corporation (PODD) shares dropped significantly after the company reported strong second-quarter results but issued a weaker-than-expected revenue forecast for the third quarter. While Q2 revenue and EPS beat estimates, the lower guidance for the upcoming quarter led to a sell-off. The stock has …

Insulet Gears Up to Face Heightened Competition in 2027

Insulet, known for its tubeless insulin pump, has enjoyed minimal direct competition for two decades, allowing it to achieve significant profitability. However, the company is preparing for heightened competition anticipated in 2027. This report highlights Insulet's business strategy and outlook in light of impending …

This Medtech Beat Earnings, but the Stock Is Having Its Worst Day in 17 Years

Insulet lowers its full-year revenue growth outlook, even after earnings and revenue handily beat expectations. Continue Reading

Oppenheimer downgrades Insulet stock rating on diabetes growth concerns

Oppenheimer downgraded Insulet Corporation (NASDAQ:PODD) to Perform from Outperform due to concerns over its growth outlook after revised guidance. The company lowered its fiscal 2026 U.S. growth forecast, attributing issues to execution challenges in Type 2 diabetes, while Oppenheimer views them as more structural. …

Insulet forecasts 2026 revenue growth of 20%-22% as it adjusts U.S. assumptions on type 2 retention

Earnings Call Insights: Insulet (PODD) Q2 2026 MANAGEMENT VIEW * Ashley McEvoy said the quarter delivered “strong revenue growth, expanding profitability and solid cash flow generation,” with total revenue up 23% year-over-year on a constant currency basis and results “exceeding our expectations.” * CEO …

Oppenheimer Downgrades Insulet Corporation (PODD) to Perform

Oppenheimer analyst Suraj Kalia has downgraded Insulet Corporation (NASDAQ: PODD) from Outperform to Perform. This decision was made on August 5, 2026, at 2:00 PM EDT. The article is a premium-only content piece, requiring a subscription to StreetInsider.com Premium for full access.

This Medtech Beat Earnings Estimates. It’s the Worst S&P 500 Stock Today.

Insulet lowers its full-year revenue growth outlook, even after earnings and revenue handily beat expectations. Continue Reading

Lost Money on Insulet Corporation (PODD)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Levi & Korsinsky, LLP is encouraging Insulet Corporation (NASDAQ: PODD) investors who suffered losses to join a class action lawsuit. The lawsuit alleges that Insulet made misleading statements regarding the manufacturing quality and safety of its Omnipod devices between February 21, 2025, and May …

Insulet Corporation stock hits 52-week low at $127.56

Insulet Corporation's stock has fallen to a 52-week low of $127.56, representing a significant decline of nearly 40% over the past year. Despite this downturn and a recent outlook reduction for the U.S. market due to customer retention issues, analysts maintain a "Buy" rating …

Insulet Reports Second-Quarter Revenue Growth as Full-Year U.S. Omnipod Outlook Is Lowered

Woman in mask and gown holding a test tube ©Adobe Stock Images The diabetes device maker exceeded second-quarter revenue guidance but reduced its full-year U.S. Omnipod sales growth forecast as it continues scaling in the type 2 diabetes market. Key Investor Takeaways Insulet (NASDAQ:PODD) …

Insulet Q2 results pressure Tandem, DexCom (PODD:NASDAQ)

Insulet Corporation's Q2 results, which included a lowered full-year revenue outlook, caused its stock to hit a 52-week low. This downturn also impacted competitors Tandem Diabetes and Dexcom, sending their shares lower. The news suggests a challenging environment for medical technology companies specializing in …

Insulet (PODD) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Insulet (PODD) reported revenue of $801.7 million, up 23.5% over the same period last year. EPS came in at $1.66, compared to $1.17 in the year-ago quarter. The reported revenue represents a surprise of +1.89% over the Zacks …

Insulet (PODD) Beats Q2 Earnings and Revenue Estimates

Insulet (PODD) came out with quarterly earnings of $1.66 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $1.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Why is Insulet stock tumbling today?

Insulet Corporation's stock tumbled 12.1% after the company released its Q2 2026 results, despite beating earnings expectations. The decline was primarily due to a meaningful cut in its full-year revenue growth forecast, driven by challenges in scaling its Omnipod platform into the type 2 …

Earnings Flash (PODD) Insulet Corporation Posts Q2 Adjusted EPS $1.66 per Share, vs. FactSet Est of $1.45

Insulet Corporation (PODD) reported its Q2 adjusted EPS at $1.66 per share, significantly exceeding FactSet's estimate of $1.45. This financial update indicates a stronger performance than anticipated by analysts for the medical device company. The article also lists recent news and analyst rating changes …

Las acciones de Insulet caen tras recortar sus previsiones de ingresos

Insulet’s (NASDAQ:PODD) Q2 CY2026 Sales Top Estimates But Stock Drops

Insulet's (NASDAQ:PODD) Q2 CY2026 Sales Top Estimates But Stock Drops Insulin delivery company Insulet Corporation (NASDAQ:PODD) announced better-than-expected revenue in Q2 CY2026, with sales up 23.5% year on year to $801.7 million. On the other hand, next quarter's revenue guidance of $833.4 million was …

Insulet's Omnipod sales hit $796M as it launches in Spain

Zacks.com featured highlights Enova, PBF, Huron , and The Cheesecake

For Immediate Release Chicago, IL – August 5, 2026 – Stocks in this week's article Enova International ENVA, Invesco Ltd. IVZ, PBF Energy PBF, Huron Consulting Group Inc. HURN and The Cheesecake Factory Inc. CAKE. 5 Stocks with Relative Price Strength Investors Should Buy …

FTI Consulting Stock Declines 4.1% Since Q2 Earnings Beat

FTI Consulting (FCN) reported Q2 2026 adjusted earnings of $2.16 per share, surpassing the Zacks Consensus Estimate by 3.4% and increasing 1.4% year-over-year. Despite the earnings beat and a 5.3% revenue rise, the stock declined 4.1% since the July 30 release due to lower …

Insulet Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PODD) 2026-08-05

Insulet Corporation (PODD) published its Q2 2026 earnings call presentation, reporting an EPS of $1.66, which beat estimates by $0.21. The company's revenue reached $801.70M, exceeding expectations by $14.27M and showing a 23.51% year-over-year increase. This presentation was released on August 5, 2026, in …

Odigma Consultancy Solutions Q1 Results FY27: PAT at Rs 15 Lakh for June 2026 Quarter

Renaissance Technologies LLC Has $8.17 Million Position in FTI Consulting, Inc. $FCN

Renaissance Technologies LLC has reduced its stake in FTI Consulting by 12.5% in the first quarter, now holding 46,200 shares valued at $8.17 million. Despite institutional investors owning 99.36% of the company, FTI Consulting reported slightly lower-than-expected earnings per share of $2.16, though revenue …

Is Now The Time To Look At Buying Real Consulting S.A. (ATH:REALCONS)?

PODD INVESTOR REMINDER: Insulet Corporation Investors Have Until August 31, 2026 To Seek Lead Plaintiff Role

Insulet Corporation investors have until August 31, 2026, to apply for the lead plaintiff role in a securities fraud class action lawsuit. The lawsuit alleges that Insulet made misleading public statements regarding defective manufacturing controls, leading to product recalls and significant stock price declines. …

Insulet Corp (PODD) SVP withholds 244 shares to cover tax obligations

Lisa Blair Davis, SVP and Chief HR Officer of Insulet Corp (PODD), reported a tax-withholding disposition of 244 shares of common stock on August 1, 2026, at a price of $165.35 per share. This transaction was executed to cover tax obligations related to the …

Insulet in focus as earnings test Type 2 diabetes momentum

Insulet Corporation is set to report second-quarter earnings, with investors keenly watching its progress in the Type 2 diabetes market amidst competitive pressures and a significant stock price decline. Analysts predict a strong quarter and see potential for considerable upside, despite recent price target …

Deadline Alert: Insulet Corporation (PODD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Insulet …

President C. Hussey Sold A Bunch Of Shares In Huron Consulting Group

C. Hussey, President of Huron Consulting Group (NASDAQ:HURN), recently sold US$4.0 million worth of company stock at US$166 per share, reducing their holding by 32%. While this was a substantial sale, it occurred at a price higher than the current share price of US$150. …

Insider Decision: Kyle Featherstone Offloads $70K Worth Of Huron Consulting Gr Stock

Kyle Featherstone, Chief Accounting Officer at Huron Consulting Gr (NASDAQ: HURN), sold 459 shares of company stock worth $70,075 on August 3, according to an SEC filing. The company shows noteworthy revenue growth, an above-average debt-to-equity ratio, and favorable valuations based on EPS, P/E, …

PODD Deadline Alert: SueWallSt Reminds Insulet Corporation (PODD) Investors of Securities Class Action Deadline on August 31, 2026

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SueWallSt notifies investors in Insulet Corporation (NASDAQ: PODD) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between February 21, 2025 and May 26, 2026. Find out if you might …

The Gross Law Firm Reminds Insulet Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 31, 2026 - PODD

The Gross Law Firm is reminding Insulet Corporation (NASDAQ: PODD) investors of a pending class action lawsuit with a lead plaintiff deadline of August 31, 2026. The lawsuit alleges that Insulet made materially false and misleading statements regarding defective manufacturing controls and procedures, creating …

Wall Street Analysts See a 27.2% Upside in Huron Consulting (HURN): Can the Stock Really Move This High?

Shares of Huron Consulting (HURN) have gained 49.9% over the past four weeks to close the last trading session at $149.96, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. …

Odigma Consultancy Solutions Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Odigma Consultancy Solutions standalone net profit rises 36.36% in the June 2026 quarter